About
Xaira Therapeutics is building a generative AI platform focused on de novo protein design and drug candidate creation, leveraging advancements from the technology behind AlphaFold. The company’s core innovation lies in applying AI to not just predict protein structures, but to generate novel protein therapeutics with optimized properties for a range of diseases. Backed by a $1 billion Series A funding round, Xaira Therapeutics aims to accelerate drug discovery beyond traditional methods and is initially focusing on developing therapeutics for currently undruggable targets.
Focus Areas
Technology Focus
drug discovery healthcare ai generative ai
Quick Stats
Total Raised $1.0B
Founded 2024
Status private
Type startup
Explore More
Similar Companies
Recursion Pharmaceuticals
Salt Lake City, United States
83%
3 shared categories
2 shared AI types
Same country
Healthcare AIDrug Discovery +1
Tempus AI
Chicago, United States
79%
2 shared categories
3 shared AI types
Same country
Healthcare AIDrug Discovery
Genesis Therapeutics
Burlingame, United States
71%
2 shared categories
2 shared AI types
Same country
Drug DiscoveryHealthcare AI
Verge Genomics
San Francisco, United States
71%
2 shared categories
2 shared AI types
Same country
Drug DiscoveryHealthcare AI